- Home
- LYFT vs LNTH Comparison
LYFT vs LNTH Comparison
Compare LYFT & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LYFT
- LNTH
- Stock Information
- Founded
- LYFT 2007
- LNTH 1956
- Country
- LYFT United States
- LNTH United States
- Employees
- LYFT N/A
- LNTH N/A
- Industry
- LYFT Business Services
- LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- LYFT Consumer Discretionary
- LNTH Health Care
- Exchange
- LYFT Nasdaq
- LNTH Nasdaq
- Market Cap
- LYFT 7.5B
- LNTH 7.2B
- IPO Year
- LYFT 2019
- LNTH 2015
- Fundamental
- Price
- LYFT $16.79
- LNTH $90.52
- Analyst Decision
- LYFT Hold
- LNTH Strong Buy
- Analyst Count
- LYFT 36
- LNTH 7
- Target Price
- LYFT $17.29
- LNTH $121.86
- AVG Volume (30 Days)
- LYFT 18.5M
- LNTH 1.6M
- Earning Date
- LYFT 11-06-2024
- LNTH 11-06-2024
- Dividend Yield
- LYFT N/A
- LNTH N/A
- EPS Growth
- LYFT N/A
- LNTH 304.57
- EPS
- LYFT N/A
- LNTH 6.02
- Revenue
- LYFT $5,460,324,000.00
- LNTH $1,496,799,000.00
- Revenue This Year
- LYFT $33.19
- LNTH $19.56
- Revenue Next Year
- LYFT $14.54
- LNTH $6.32
- P/E Ratio
- LYFT N/A
- LNTH $15.03
- Revenue Growth
- LYFT 25.41
- LNTH 24.15
- 52 Week Low
- LYFT $8.93
- LNTH $50.20
- 52 Week High
- LYFT $20.82
- LNTH $126.89
- Technical
- Relative Strength Index (RSI)
- LYFT 58.81
- LNTH 45.56
- Support Level
- LYFT $16.26
- LNTH $75.00
- Resistance Level
- LYFT $18.57
- LNTH $118.21
- Average True Range (ATR)
- LYFT 0.77
- LNTH 5.13
- MACD
- LYFT -0.12
- LNTH 0.13
- Stochastic Oscillator
- LYFT 58.60
- LNTH 38.71
About LYFT Lyft Inc.
Lyft is the second-largest ride-sharing service provider in the US and Canada, connecting riders and drivers over the Lyft app. Incorporated in 2013, Lyft offers a variety of rides via private vehicles, including traditional private rides, shared rides, and luxury ones. Besides ride-share, Lyft also has entered the bike- and scooter-share market to bring multimodal transportation options to users.
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.